Yousefi, B., Samadi, N., Baradaran, B., Rameshknia, V., Shafiei-Irannejad, V., Majidinia, M., Targhaze, N. and Zarghami, N. 2015. Differential effects of peroxisome proliferator-activated receptor agonists on doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells. Cellular and Molecular Biology. 61, 8 (Dec. 2015), 118–122.